CHU Nimes
Nîmes, 30029, France
NCT Number: NCT03408288
The investigators hypothesize that incorporation of a colorimetric scale on urine collection bags to estimate degree of hematuria would allow better characterization of urine by healthcare staff thus leading to improved patient care.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Nîmes, 30029, France
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Use of Hemapoche scale to assess hematuria in reference samples
Use of Hemastick scale to assess hematuria in reference samples
Describe color of reference sample
Time frame: Baseline
Kappa coefficient
Time frame: Baseline
Kappa coefficient
Time frame: Baseline
Kappa coefficient
Time frame: Baseline
Kappa coefficient
Time frame: Baseline
Kappa coefficient
Time frame: Baseline
Kappa coefficient
Time frame: Baseline
Seconds (less than one minute)
Time frame: Baseline
Seconds (less than one minute)
Time frame: Baseline
Seconds (less than one minute)
Time frame: Baseline
Visual analog scale (0-10)
Time frame: Baseline
System usability scale (0-10)
Centre Hospitalier Universitaire de Nīmes
Other
Acronym: HEMAPOCHE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04943380
Carcinoma, Carcinoma, Transitional Cell
San Diego, California, United States
View Trial DetailsNCT02276924
Cancer of Urinary Tract, Female Urogenital Diseases
Lille, Hauts-de-France, France
View Trial DetailsNCT03988309
Carcinoma, Carcinoma, Transitional Cell
Los Angeles, California, United States
View Trial DetailsNCT04971057
Anxiety, Anxiety Disorders
Taoyuan, Taiwan
View Trial Details